Back to Top Skip to main content Skip to sub-navigation

DTRA contributes to historic Ebola vaccine effort

Air Force Staff Sgt. Lee Nembhard, an aeromedical evacuation technician assigned to the 375th Aeromedical Evacuation Squadron from Scott Air Force Base, Illinois, straps a simulated Ebola patient to a litter during a Transport Isolation System training exercise at Joint Base Charleston, South Carolina. (U.S. Air Force photo by Senior Airman Megan Munoz) Air Force Staff Sgt. Lee Nembhard, an aeromedical evacuation technician assigned to the 375th Aeromedical Evacuation Squadron from Scott Air Force Base, Illinois, straps a simulated Ebola patient to a litter during a Transport Isolation System training exercise at Joint Base Charleston, South Carolina. (U.S. Air Force photo by Senior Airman Megan Munoz)

Recommended Content:

Immunization Healthcare | Immunizations | Global Emerging Infections Surveillance | Global Health Engagement

FORT BELVOIR, Va. — The team of researchers and program managers at the Defense Threat Reduction Agency (DTRA) that has worked to counter the threat of the Ebola Virus Disease (EVD) welcomed the announcement of the U.S. Food and Drug Administration’s (FDA) approval of the vaccine, Ervebo ®, to the pharmaceutical company Merck & Co., Inc., December 19, 2019.

The approval of the vaccine represents the culmination of nearly two decades of efforts by a host of teams from across the public and private sectors such as DTRA and Merck, international partners in North America, Europe and Africa, and non-governmental and international organizations. The World Health Organization (WHO) describes EVD as a rare but severe hemorrhagic fever. EVD has killed thousands over the course of outbreaks, primarily in sub-Saharan Africa, since it first appeared in the 1970s.

DTRA, a Department of Defense combat support agency that identifies and combats biological threats as part of its mission to counter weapons of mass destruction (WMD), began its work on the vaccine in 2014 during an especially deadly outbreak in West Africa. The outbreak made clear the danger EVD posed to U.S. national security interests abroad, as well as to the U.S. domestic population in the event of a pandemic. To counter the threat, DTRA quickly initiated a strategy to get a vaccine approved. The combat support agency coordinated a series of investment efforts and partnerships to deliver a baseline platform for a viable vaccine candidate to mitigate the spread of the deadly disease.

“DTRA’s agile contracting, and well-placed contacts throughout government, academia, and industry allowed DTRA to form partnerships and guide development of this vaccine from the early stages of development, through crucial preclinical, and critical phase 1 clinical safety trials to the actual phase 2 clinical efficacy trial that demonstrated effectiveness of this vaccine during the outbreak,” said L. Revell Phillips Ph.D., a member of DTRA’s research and development team.

DTRA’s pioneering approach started with a contract to BioProtection Systems, a small biotech company. DTRA and BioProtection Systems partnered with Public Health Agency Canada, who began developing the vaccine in 2001, to accelerate its development. With these three teams working together, the vaccine progressed to a series of nonclinical and clinical studies conducted at the U.S. Army Medical Research Institute of Infectious Disease (USAMRIID) and Walter Reed Army Institute of Research (WRAIR) defense laboratories.

As the effort evolved, DTRA leveraged its USAMRIID partner’s research capacity, resulting in international partnering agreements with the WHO. DTRA also coordinated with teams across the U.S. government as development of the vaccine progressed. The efforts of this research and development consortium produced viable data that would be transitioned to next-level partners.

“We exercised our ability to develop partnerships for a relevant need, which was critical in transitioning medical countermeasures to our advanced developers at the speed of relevancy,” said Army Maj. Jeffrey Froude, DTRA’s program manager for the EVD Vaccine.

Froude explained that DTRA bolstered its research and development investments through two key U.S. governmental partners. First, DTRA worked closely with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, for advanced trials and manufacturing activities. Second, DTRA teamed with the DoD’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) for the task of immunoassay development. For that development effort, JPEO-CBRND’s, office of the Joint Program Manager for CBRN Medical took the lead.

Following several years of coordinated research and development efforts by the coalition of partners, the promising vaccine candidate transitioned to next-level partners BARDA and Merck for more advanced human clinical trials and product manufacturing of the EVD vaccine.

“This vaccine’s rapid progress is a testament to the power of partnerships among government agencies and with the private sector,” said BARDA director Rick Bright.

Next-level partner BARDA and Merck, served as the transition point to conduct more advanced human clinical trials and product manufacturing on the Ebola vaccine with the Joint Program Executive office (JPEO) providing a testing capability that allowed Merck to test human and non-human primate samples. The Joint Project Manager for Chemical, Biological, Radiological and Nuclear Medical (JPM-CBRN), Army Col. Ryan Eckmeier, stated that this “interagency partnership from the beginning was critical to advancing this vaccine product.”

Merck’s expertise with licensing and manufacturing was instrumental in advancing the vaccine. The pharmaceutical giant partnered with the WHO, United Nations International Children's Emergency Fund, and Gavi Vaccine Alliance, among others, to strategize on how to best implement future public health preparedness and response efforts against EVD.

“We share in this achievement, and thank you all personally for your amazing support over the last five years,” said Beth-Ann G. Coller, executive director of Merck’s vaccine team in a note to the DTRA team. “This has truly been a journey and one that we are proud to have shared with our colleagues in DoD. Without the early and continued support of DTRA we would not be here today.”

DTRA continues to leverage its successful partnerships as the agency works to develop future countermeasures. DTRA and BARDA have active partnering agreements to develop vaccine and therapeutic medical countermeasures to address a diverse range of viral and bacterial infectious disease threats. Efforts will use a similar model to the one that supported development and approval of the EVD vaccine.

“As DTRA moves forward to new challenges, we will leverage continued utilization of the Ebola vaccine model, using a diverse range of ways that we can work with our academic, international, interagency and industrial partners through grants, contracts and other transaction authorities,” said Froude. “We have a proven paradigm on how to efficiently advance medical countermeasures working with our U.S. government partners in these endeavors.”

Disclaimer: Re-published content may be edited for length and clarity. Read original post.

You also may be interested in...

Flu Vaccination Rates are Running High Across the Military This Year

Article
12/1/2021
Image of a woman giving someone an injection on the arm.

Rates of flu vaccination among service members are significantly higher than in previous years.

Recommended Content:

Seasonal Influenza Vaccine Toolkit | Medical and Dental Preventive Care Fitness | Immunizations | Influenza, Northern Hemisphere

Army Recovery Care Coordinator Guides Veterans, Caregivers in Recovery

Article
11/12/2021

A warrior care coordinator shares how she supports recovering service members, their families and caregivers.

Recommended Content:

Health Readiness | IHD COVID-19 Vaccine Resource Center for Health Care Personnel | Immunization Healthcare

Flu Shots are Available Now And Are More Important than Ever

Article
10/13/2021
Military personnel getting their flu shot

It’s flu season. Get vaccinated. COVID-19 concerns should redouble desire to get vaccinated against the flu.

Recommended Content:

Seasonal Influenza Vaccine Toolkit | Immunizations | Medical and Dental Preventive Care Fitness | Influenza, Northern Hemisphere

International Partnerships Foster Improvements in Military Health Care

Article
9/23/2021
Dr. Smith presenting at a podium

U.S. Deputy Assistant Secretary of Defense for Health Readiness Policy and Oversight Dr. David Smith spoke about what makes global health, specifically military partnerships, work as part of the ICMM’s "Centennial Talks," in Schelle, Belgium.

Recommended Content:

Global Health Engagement | Dr. David J. Smith | Uniformed Services University of the Health Sciences

Gen. George Washington Ordered Smallpox Inoculations for All Troops

Article
8/16/2021
Old photo of George Washington in battle

George Washington’s tactics included directing the first mass military inoculations

Recommended Content:

Military Medical History | Immunizations

Don't Hesitate: Vaccinate Today for School

Article
8/13/2021
A boy gets the COVID-19 vaccine

Back to School Means Vaccine Time

Recommended Content:

COVID-19 Vaccine Efforts | Coronavirus | Immunization Healthcare | Vaccine-Preventable Diseases | Vaccine Recommendations | Children's Health | Immunizations | TRICARE Health Program

MHS and MOS Town Hall To Your Health: Back to School

Article
8/10/2021
Infographic about the To Your Health Town Hall

MHS and Military OneSource presents a summer safety discussion with experts about Back to School Vaccinations and Beyond

Recommended Content:

Immunization Healthcare | Vaccine-Preventable Diseases | Children's Health | MHS and Military OneSource To Your Health

How You Can Prevent This Cancer-Causing Sexually Transmitted Infection

Article
8/4/2021
Doctor talking to a boy

Get the HPV vaccinations for cancer prevention if you haven’t already

Recommended Content:

Immunization Awareness Month | Medical and Dental Preventive Care Fitness | Children's Health | Immunizations

Eight nations participate in West African virtual pandemic exercise

Article
3/24/2021
Picture of military personnel wearing a face mask looking at a laptop computer

Medical experts from six African nations, the United Kingdom and the United States, participated in a Virtual Pandemic Preparation and Response Engagement exercise.

Recommended Content:

MHS Toolkits and Branding Guidance | Coronavirus | Global Health Engagement | Partners

New Army surveillance program designed to keep service members safe

Article
3/10/2021
Military personnel wearing a face mask hanging a light in a tree

Collecting vector samples allows for PHC-P scientists to analyze areas of interest for potential vector-borne diseases that could impact the health of the force.

Recommended Content:

Public Health | Global Health Engagement | Bug-Borne Illnesses | Mosquito-Borne Illnesses

Trained military personnel ready to help with COVID-19 vaccinations

Article
2/23/2021
Military health personnel wearing a mask giving the COVID-19 vaccine to a man who is also wearing a face mask

Military prepped and ready to help with civilian COVID-19 mass vaccinations

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | Immunizations

Order of Military Medical Merit presented to USU medical student

Article
2/19/2021
Military personnel receiving the Order of Military Merit

Army 2nd becomes the first USU medical student to receive the Order of the Military Medical Merit.

Recommended Content:

Combat Support | Health Readiness | Global Health Engagement

Marines, Sailors with PHIBRON 11, 31st MEU receive COVID-19 vaccine

Article
2/19/2021
Military health personnel giving the COVID-19 Vaccine to military personnel

Vaccination for service members is voluntary, as vaccines are currently authorized for emergency use.

Recommended Content:

Coronavirus | Immunization Healthcare | COVID-19 Vaccine Efforts

USU cohort study investigates COVID-19 impacts on DOD personnel

Article
2/18/2021
Military health personnel wearing a mask and a face shield holding up a sign that has the number eighteen on it

USU is conducting a study to better understand the symptoms and course of COVID-19 disease and identify risk factors in the military population.

Recommended Content:

MHS Toolkits and Branding Guidance | Immunizations | COVID-19 Vaccine Efforts | Coronavirus

AFHSD’s GEIS collect data worldwide to support force protection

Article
12/22/2020
Medical personnel scanning forehead of soldier with thermometer

AFHSD/GEIS continue work with partners across the globe in their efforts to combat COVID-19 and protect military readiness.

Recommended Content:

Health Readiness | Public Health | Coronavirus | Biological Surveillance Tools | Global Health Engagement | Armed Forces Health Surveillance Division | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit
<< < 1 2 3 4 > >> 
Showing results 1 - 15 Page 1 of 4

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.